BDBM350533 N-(4-bromophenyl)-2-(4-ethyl-4- methyl-2,5-dioxoimidazolidin-1- yl)acetamide::US10208071, Table 3.9::US10799518, Structure TABLE 3.9

SMILES CCC1(C)NC(=O)N(CC(=O)Nc2ccc(Br)cc2)C1=O

InChI Key InChIKey=LTSWISVZDXQGQX-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 350533   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350533(N-(4-bromophenyl)-2-(4-ethyl-4- methyl-2,5-dioxoim...)
Affinity DataEC50:  485nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350533(N-(4-bromophenyl)-2-(4-ethyl-4- methyl-2,5-dioxoim...)
Affinity DataEC50:  4.85E+5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent